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AGRICULTURAL BIOTECHNOLOGY
AT THE CROSSROADS AN OVERVIEW
The National Agricultural Biotechnology Council’s Third Annual Meet-
ing was held in cooperation with the University of California Agricultural 
Issues Center at the end of May, 1991. Focusing on the theme “Agricultural 
Biotechnology at the Crossroads,” the meeting 
offered the opportunity to assess the current 
status and potential future impacts of agricul-
tural biotechnology. The last decade saw many 
people project agricultural biotechnology’s po-
tential to raise productivity—yet that reality 
has not yet been achieved. Why?
More importantly, what does and should the 
future hold for creating an environment in 
which agricultural biotechnology can safely 
and acceptably be used to enhance productiv-
ity in agriculture?
The Third Annual Meeting was organized to 
address these questions and to:
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—promote dialog and understanding among 
those with differing views;
—establish a common knowledge base and 
identify areas of disagreement both of fact and 
perception;
—reach consensus where possible on specific 
areas needing additional research, education or 
study;
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—develop criteria for evaluating the appropri-
ateness of constraints and incentives currently 
impeding or promoting the research, commer-
cialization and acceptance of products;
—develop specific recommendations, includ-
ing policy options.
The meeting clearly promoted an exchange of views among individuals 
from diverse backgrounds, including animal, plant and social scientists, 
administrators, various interest groups (farmers, consumers, environ-
mentalists and animal welfare groups) and entrepreneurs. With each 
NABC meeting the number and diversity of participants expands.
An even mix of lectures and workshop sessions provided participants 
with many opportunities to speak, listen and learn. The lectures included 
visions of agricultural biotechnology’s future and assessments of the sta-
tus quo of various biotechnologies, institutional concerns and socioeco-
nomic issues. Presentations and white papers on four “national issues” 
provided a common foundation for the four workshops—herbicide toler-
ance in crops, biological control of pests, transgenic animals and animal 
growth promotants.
MAJOR CURRENTS
Over the course of two and half days, several themes emerged:
Agricultural biotechnology should not be viewed as an end in itself, rather, 
as a set of tools which might be used to achieve societal goals, whatever 
those might be. Margaret Mellon’s talk, “Biotechnology and the Environ-
mental Vision” (see page 66) precipitated discussions on this area 
throughout the meeting. The choice and development of agricultural pro-
duction systems should be made with society’s environmental goals in 
mind.
Keynote speaker Walter Truett Anderson’s talk “The Past and Future of 
Agriculture,” (see page 53) focused on the increasing awareness of how hu-
man actions affect the environment. Concern for the environment and lim-
ited global resources, along with an increasing ability to measure and de-
tect these changes, will play a major role in determining acceptable agri-
cultural production decisions in the future, necessitating long-term plan-
ning. Many at the meeting felt that agricultural research funding should be 
strengthened. Secure funding compatible with the nature of the research 
(i.e., commitment of funds for 10-year periods rather than the usual one 
to three year period) may assist in shifting the national planning horizon 
to the long term. At the same time, socioeconomic studies designed to re-
veal societal preference patterns, among other things, also should be 
funded.
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Preserving the “family farm” was often mentioned, particularly in the 
workshops, as a desirable social goal which is believed to be at risk as agri-
cultural biotechnologies become more widespread. However, the family 
farm is threatened by other sources more imminent than those posed by 
agricultural biotechnology—for instance, the high cost of current farm 
programs.
In order to remain competitive in world markets, the United States may 
need to have a mixture of agricultural technologies available. Develop-
ments in other parts of the world may hold serious implications for U.S. 
agricultural trade, particularly those involving the use of agricultural bio-
technologies.
The regulatory systems involved with agricultural biotechnology need to 
be clearly delineated, available to the public and industry and subject to 
continual scrutiny. The regulatory system should not stifle basic research 
and should be protective of human and animal welfare.
VISIONARY PATHWAYS
The keynote speaker, journalist, political scientist and author Walter 
Truett Anderson suggested that agricultural biotechnology will have an 
impact comparable to the industrial revolution on today’s productivity 
and life-styles. Urging those with vested interests to engage in open dis-
cussions on the potential impact of agricultural biotechnology, he em-
phasized the need to abandon “satanic” views of biotechnology in favor of 
examining what uses, both economic and humanitarian, we have for these 
tools. He reminded us that the history of humankind has continually been 
one of adapting the environment to suit particular purposes and that it is 
appropriate to consider the emergence of agricultural biotechnology as 
but one event in a chronology of discoveries which commenced when hu-
mans first started planting grains.
Reiterating stages proposed by NABC Chair Ralph W. F. Hardy in his 
charge to the meeting, Anderson spoke of our passing through a stage of 
“active science” (1860s - early 1970s) and a “transitional era” (early 1970s 
- early 1990s) and now of entering a “product era,” characterized by large 
risks and large rewards, where products based on agricultural biotechnol-
ogy will be developed. How well has society coped with the evolutionary 
process? Anderson says it is “a mixed bag,” with some logical responses as 
well as some rather chaotic ones.
Agricultural Biotechnology at the Crossroads
Margaret G. Mellon and Jerry Caulder followed Anderson with alter-
native views on the future of agricultural biotechnology. For Mellon, the 
Director of the National Biotechnology Policy Center, National Wildlife 
Federation, agricultural biotechnology should be examined within the 
context of broader social goals—fundamental goals such as chemical-free 
agriculture should be high on the agenda for public debate. She presented 
a vision of prosperous farmers, an abundance of safe and affordable food 
and a clean environment, suggesting that biotechnology was dampening 
our progress towards a sustainable agriculture. Mellon suggested that the 
agri-biotechnology industry was indeed facing a crossroads regarding 
commercialization, adding that credible regulatory programs are needed 
now if transgenic products are to reach the marketplace.
Caulder, President and CEO of Mycogen Corporation and Chair of the 
Industrial Biotechnology Association, enthusiastically spoke of the future 
of agricultural biotechnology, noting we are on the verge of having an im-
pressive portfolio of products. He cited increased production efficiency as 
a path that will benefit all consumers, adding that the public needs to be 
better informed about the associated risks and benefits with new prod-
ucts. Caulder believes that agriculture would be more at risk if biotech-
nology is abandoned than if biotechnology becomes commonplace. Not-
ing that the 60 day food “surplus” in the world is really an inadequate “re-
serve,” he called for more funding in the agricultural biotechnology area 
for basic research to insure that the best scientists are attracted to the area.
ON THE FRONTIERS
Looking at the frontiers of biotechnology, ten speakers attempted to an-
swer the questions, “Where are we now? What factors are, can and should 
impede progress?”
Covering biological breakthroughs and bottlenecks, Calvin Qualset, 
the Director of the Genetic Resources Conservation Program at the Uni-
versity of-California-Davis, Winston J. Brill, principal of Winston J. Brill 
& Associates Consulting and George E. Seidel Jr., an animal physiologist 
at Colorado State University, all spoke about the “cutting edge” of bio-
technology and its potential applications, reminding us of the frustrations 
and obstacles (biological, financial and regulatory) facing rapid develop-
ment and release of new agricultural biotechnologies. Time delays associ-
ated with field testing are but one example.
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The next four speakers broadened the scope of discussion, lending their 
expertise to examine issues beyond the laboratory—the institutional in-
centives and impediments to agricultural biotechnology. Robert B. Ni-
cholas, a partner at the Washington law firm of McDermott, Will & Emery 
and Executive Director, NABC, called for a shorter and less costly regula-
tory framework based on the products of agricultural biotechnology 
rather than on the research-discovery process. Guidelines should be clear 
regarding jurisdiction in the various areas, a system which the public 
trusts, and should allow for and encourage discussion.
Offering an assessment of the incentives related to property rights, 
William H. Lesser, an agricultural economist at Cornell University, 
pointed out that companies have little incentive to invest in research or 
product development without sufficient reassurance that they can recoup 
research and development costs through ownership of resulting processes 
and products. On the other hand, university scientists who conduct much 
of the research have strong incentives to publish research results and uni-
versity administrators often want ownership of those discoveries which 
might have commercial possibilities. Lesser identified several areas where 
intellectual property laws should be reexamined to “achieve a better bal-
ance between private incentive and public well-being”. Examples include 
the laws regarding the patenting of “pioneering discoveries” and the U.S. 
“first-to-invent” system. However, he felt that the state of intellectual 
property protection in the United States is quite extensive and its short-
comings are not principally responsible for the slow commercialization of 
products.
Roger Salquist, Chair and CEO of Calgene, Inc., followed with a discus-
sion of some of the problems associated with commercialization, identify-
ing the slow nature of the science as a serious “structural impediment”. 
Lack of funding, from both the private and public sectors, also slows re-
search and development as well as the “convoluted” structure of agricul-
ture resulting from government interventions—although he did not feel 
that the criticism of regulatory agencies regarding procedures and delays 
for obtaining field trial approvals is warranted.
The public sector’s role in agricultural biotechnology was addressed by 
Charles Hess, the Assistant Secretary for Science and Education at the 
United States Department of Agriculture (USDA), noting that as agribusi-
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ness becomes more market-oriented, it is the university and government 
laboratories that must play an ever increasing role in doing research in 
biotechnology that may not lead to a definitive product. A strong national 
commitment to funding for agricultural biotechnology is essential for 
U.S. competitiveness. It is also in the public’s interest to insure that the 
best and the brightest women and men are attracted to and remain in ag-
ricultural science. Taking exception with those who maintain biotechnol-
ogy would compete with sustainable agriculture, Hess maintained that 
“biotechnology can help agriculture be sustainable, productive and nutri-
tious.”
Economic issues also factor into decisions to develop and use agricul-
tural biotechnologies. Susan Offutt, Chief, Agriculture Branch at the Of-
fice of Management and Budget, presented two situations which could 
have a profound influence on agricultural production decisions. One, 
farming will become more competitive if the current round of General 
Agreement on Tariffs and Trades (GATT) negotiations results in a dis-
mantling of domestic farm programs and freer international trade in agri-
cultural products. She anticipates that farmers will respond by diversify-
ing output mixes more than at present. Two, the Clean Water Act is due 
for re-authorization during the current session of Congress, and atten-
tion will focus on farming’s contribution to surface water quality degra-
dation. The “price” of using the natural environment will likely rise. In 
both cases, the choice of inputs and outputs will be weighed more care-
fully by farmers. The products of biotechnology must show a positive 
contribution to agriculture if biotechnology is to be accepted.
William Lacy, the Assistant Dean for Research, Pennsylvania State Uni-
versity, presented the fourth criterion as an essential element in evaluat-
ing future research and developments in biotechnology—and asked if it 
should really be considered the “first criterion.” He emphasized that bio-
technology presents tools to move toward social and economic goals, but 
also has the potential to increase inequities among groups in the U.S. and 
between developed and developing countries. Lacy suggested we therefore 
need the fourth criterion as part of our decision-making process.
The final speaker, Michael Hansen, Project Leader at the Consumers 
Union, believes that consumers are better informed about developments 
in agricultural biotechnology than is commonly thought. Noting that the
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consumer will and should be demanding information on products from 
agricultural biotechnology, he said that consumers rank drug companies 
as the least credible source of information about food quality and safety. 
Critical of several public agency procedures, Hansen called for more gov-
ernmental and industrial accountability to the public.
Th e  Workshops: National  Issues
Four workshops offered all participants the opportunity to speak, to lis-
ten, and to learn. White papers (see page 177) were distributed to work-
shop registrants prior to the meeting as background material for each 
workshop and general information on each topic was presented during 
the meeting in a session on “national issues.” A feature common to all 
workshops was the variety of backgrounds and interests of the partici-
pants.
Herbicide tolerance in crops—this workshop addressed the questions, 
“What is the probable role of herbicide tolerant crops in agricultural pro-
duction?” and “What are the benefits and risks associated with their use?”
Biological control of pests—this workshop developed strategies for a na-
tional effort to make biological control viable for farmers, consumers and 
agribusiness, as well as safe for the environment.
Transgenic animals—a less developed area, this workshop examined the 
technical difficulties, achievements and physiological consequences of 
producing transgenic animals. Associated moral and ethical issues, and 
health and food safety concerns were raised.
Animal growth promotants—this workshop had the goal of assessing 
the biological, socioeconomic, health and safety, environmental quality 
and communications problems associated with the commercialization of 
animal growth promotants.
Recommendations developed in these workshops can be found on 
pages 11 -15 and full summaries on pages 27 - 49.
CROSSROADS
While workshops and lectures helped to identify areas of common ground 
between participants, there were also many areas where consensus was 
not developed, most noticeably in the area of specific solutions. Many 
questions were left unanswered. “What is an appropriate level of research
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funding? Who should set and monitor ethical standards in relation to re-
search? Who should carry out impact studies? Who should be regulated? 
How? Who should address international concerns, and how?”
Although many questions remain, this meeting provided the unique 
opportunity for people from various constituencies with different values 
and agendas to begin to forge new relationships with groups previously 
considered opponents, and to begin to understand some of the common, 
and not-so-common, concerns.
Patricia B. Swan, Interim Provost, Iowa State University, summed up 
the meeting, identified both roads which have already been crossed, and 
many which are yet to come. Roads crossed include the definition of agri-
cultural biotechnology as “a set of methods or tools used in living sys-
tems” as well as the acceptance that these tools will be used and regulated 
(see page 16).
Crossroads facing us now include “What will drive the future of agri-
culture and agricultural biotechnology” and “Will technology, economics 
or social concerns dominate widespread regulatory concerns; insuring 
communication among the public, the scientists, the agribusiness sector 
and the regulators; and the issue of funding.” One of the most problem-
atic crossroads identified was “Who gets to decide these questions?” 
which only serves to emphasize the importance of open forums such as 
NABC3.
In closing, Swan asked, “How vigorous and fearless was our examina-
tion of the issues?,” adding that while she had seen some “fairly coura-
geous sifting and winnowing in the last two days,” the discussions devel-
oped at the meeting should continue. There is a need for more coopera-
tive exploration of the roads ahead.
Agricultural Biotechnology at the Crossroads was a crossing of many 
visions and values in agricultural biotechnology. With this brief meeting, 
many points of view have come to the fore, hopefully initiating discus-
sions and understandings and the next steps toward consensus building 
on the roles of biotechnology in agriculture.
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